Skip to main content

Table 1 The Baseline Characteristics of the Patients

From: Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems

  

Cefmetazole group

Carbapenems group

p value

 

number

26

43

-

 

male

12

22

-

 

age

67.5

71.2

-

Source

UTI

18 (69 %)

17 (40 %)

-

Pathogen

E.coli

25 (96 %)

39 (91 %)

-

Outcome

survive without relapse

25

36

0.243

death

1

5

relapse

0

2

Patient profile

SOFA

2.8 + -2.8

5.0 + -4.5

0.055

Charlson

7.1 + -3.4

6.8 + -2.8

0.85

Pitt. Bact. Score

1.5 + -1.5

2.5 + -2.1

0.048

admission to ICU

5 (24 %)

17 (39 %)

0.111

community acquired

10 (38 %)

11(26 %)

0.29

Bacterial profile

mixed infection

2 (8 %)

7 (16 %)

0.466

cefmetazole:R

0 (0 %)

1 (2 %)

1

fluoroquinolone:R

19 (73 %)

34 (79 %)

1

Treatment profile

ID consult

19 (73 %)

21 (49 %)

0.077

empiric cover

13 (50 %)

27 (63 %)

0.325